Bioprinting the Cancer Microenvironment

Author:

Zhang Yu Shrike123,Duchamp Margaux124,Oklu Rahmi5,Ellisen Leif W.6,Langer Robert27,Khademhosseini Ali12389

Affiliation:

1. Biomaterials Innovation Research Center, Division of Biomedical Engineering, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, 65 Landsdowne Street, Cambridge, Massachusetts 02139, United States

2. Harvard−MIT Division of Health Sciences and Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States

3. Wyss Institute for Biologically Inspired Engineering, Harvard University, 3 Blackfan Circle, Boston, Massachusetts 02115, United States

4. Department of Bioengineering, École Polytechnique Fédérale de Lausanne, Route Cantonale, Lausanne 1015, Switzerland

5. Division of Vascular & Interventional Radiology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, Arizona 85259, United States

6. Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, United States

7. Department of Anesthesiology, Boston Children’s Hospital, 300 Longwood Avenue, Boston, Massachusetts 02115, United States

8. Department of Bioindustrial Technologies, College of Animal Bioscience and Technology, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of Korea

9. Department of Physics, King Abdulaziz University, Abdullah Sulayman Street, Jeddah 21569, Saudi Arabia

Funder

National Cancer Institute

National Institute of Dental and Craniofacial Research

National Institute of Biomedical Imaging and Bioengineering

Office of Naval Research

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institutes of Health

Publisher

American Chemical Society (ACS)

Subject

Biomedical Engineering,Biomaterials

Reference116 articles.

1. World Cancer Report 2014;Stewart, B. W., Wild, C. P., Eds.International Agency for Research on Cancer, World Health Organization:Lyon, France, 2014.

2. Hypoxia — a key regulatory factor in tumour growth

3. Hypoxia, HIF1 and glucose metabolism in the solid tumour

4. Exploiting tumour hypoxia in cancer treatment

5. Hallmarks of Cancer: The Next Generation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3